Feb 07, 2023 8:30am EST Virax Biolabs Group Limited Announces Purchase Order to Launch COVID-19 and Influenza A+B Antigen Combo Rapid Tests with Cosmos Health (NASDAQ:COSM)
Dec 06, 2022 7:30am EST COVID-19 Rapid Antigen Test Distributed By Virax Biolabs Receives Emergency Use Authorization in the United States
Nov 15, 2022 7:30am EST Virax Biolabs Appoints Richard Pallin as the Vice President of In Vitro Diagnostic Sales
Nov 08, 2022 4:30pm EST Virax Biolabs Group Limited Announces Closing of $3.8 Million Private Placement
Nov 03, 2022 7:30am EDT Virax Biolabs Introduces RSV-Influenza-COVID Triple Virus Antigen Rapid Test Kit
Oct 26, 2022 7:30am EDT Virax Biolabs Group Limited Announces Initiation of its Virax Immune COVID-19 Analytical Performance Study
